Implementation of a multidisciplinary pharmacogenomics clinic in a community health system
The development and implementation of a multidisciplinary pharmacogenomics clinic within the framework of an established community-based medical genetics program are described. Pharmacogenomics is an important component of precision medicine that holds considerable promise for pharmacotherapy optimi...
Saved in:
Published in: | American journal of health-system pharmacy Vol. 73; no. 23; pp. 1956 - 1966 |
---|---|
Main Authors: | , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
England
Oxford University Press
01-12-2016
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | The development and implementation of a multidisciplinary pharmacogenomics clinic within the framework of an established community-based medical genetics program are described.
Pharmacogenomics is an important component of precision medicine that holds considerable promise for pharmacotherapy optimization. As part of the development of a health system-wide integrated pharmacogenomics program, in early 2015 Northshore University Health-System established a pharmacogenomics clinic run by a multidisciplinary team including a medical geneticist, a pharmacist, a nurse practitioner, and genetic counselors. The team identified five key program elements: (1) a billable-service provider, (2) a process for documentation of relevant medication and family histories, (3) personnel with the knowledge required to interpret pharmacogenomic results, (4) personnel to discuss risks, benefits, and limitations of pharmacogenomic testing, and (5) a mechanism for reporting results. The most important program component is expert interpretation of genetic test results to provide clinically useful information; pharmacists are well positioned to provide that expertise. At the Northshore University HealthSystem pharmacogenomics clinic, patient encounters typically entail two one-hour visits and follow a standardized workflow. At the first visit, pharmacogenomics-focused medication and family histories are obtained, risks and benefits of genetic testing are explained, and a test sample is collected; at the second visit, test results are provided along with evidence-based pharmacotherapy recommendations.
A multidisciplinary clinic providing genotyping and related services can facilitate the integration of pharmacogenomics into clinical care and meet the needs of early adopters of precision medicine. |
---|---|
AbstractList | PurposeThe development and implementation of a multidisciplinary pharmacogenomics clinic within the framework of an established community-based medical genetics program are described.SummaryPharmacogenomics is an important component of precision medicine that holds considerable promise for pharmacotherapy optimization. As part of the development of a health system-wide integrated pharmacogenomics program, in early 2015 Northshore University Health-System established a pharmacogenomics clinic run by a multidisciplinary team including a medical geneticist, a pharmacist, a nurse practitioner, and genetic counselors. The team identified five key program elements: (1) a billable-service provider, (2) a process for documentation of relevant medication and family histories, (3) personnel with the knowledge required to interpret pharmacogenomic results, (4) personnel to discuss risks, benefits, and limitations of pharmacogenomic testing, and (5) a mechanism for reporting results. The most important program component is expert interpretation of genetic test results to provide clinically useful information; pharmacists are well positioned to provide that expertise. At the Northshore University HealthSystem pharmacogenomics clinic, patient encounters typically entail two one-hour visits and follow a standardized workflow. At the first visit, pharmacogenomics-focused medication and family histories are obtained, risks and benefits of genetic testing are explained, and a test sample is collected; at the second visit, test results are provided along with evidence-based pharmacotherapy recommendations.ConclusionA multidisciplinary clinic providing genotyping and related services can facilitate the integration of pharmacogenomics into clinical care and meet the needs of early adopters of precision medicine. Purpose. The development and implementation of a multidisciplinary pharmacogenomics clinic within the framework of an established community-based medical genetics program are described. Summary. Pharmacogenomics is an important component of precision medicine that holds considerable promise for pharmacotherapy optimization. As part of the development of a health system-wide integrated pharmacogenomics program, in early 2015 Northshore University HealthSystem established a pharmacogenomics clinic run by a multidisciplinary team including a medical geneticist, a pharmacist, a nurse practitioner, and genetic counselors. The team identified five key program elements: (1) a billable-service provider, (2) a process for documentation of relevant medication and family histories, (3) personnel with the knowledge required to interpret pharmacogenomic results, (4) personnel to discuss risks, benefits, and limitations of pharmacogenomic testing, and (5) a mechanism for reporting results. The most important program component is expert interpretation of genetic test results to provide clinically useful information; pharmacists are well positioned to provide that expertise. At the Northshore University HealthSystem pharmacogenomics clinic, patient encounters typically entail two one-hour visits and follow a standardized workflow. At the first visit, pharmacogenomics-focused medication and family histories are obtained, risks and benefits of genetic testing are explained, and a test sample is collected; at the second visit, test results are provided along with evidence-based pharmacotherapy recommendations. Conclusion. A multidisciplinary clinic providing genotyping and related services can facilitate the integration of pharmacogenomics into clinical care and meet the needs of early adopters of precision medicine. Keywords: pharmacogenomics, pharmacogenetics, medication therapy management, precision medicine, clinical implementation, comprehensive medication management The development and implementation of a multidisciplinary pharmacogenomics clinic within the framework of an established community-based medical genetics program are described. Pharmacogenomics is an important component of precision medicine that holds considerable promise for pharmacotherapy optimization. As part of the development of a health system-wide integrated pharmacogenomics program, in early 2015 Northshore University Health-System established a pharmacogenomics clinic run by a multidisciplinary team including a medical geneticist, a pharmacist, a nurse practitioner, and genetic counselors. The team identified five key program elements: (1) a billable-service provider, (2) a process for documentation of relevant medication and family histories, (3) personnel with the knowledge required to interpret pharmacogenomic results, (4) personnel to discuss risks, benefits, and limitations of pharmacogenomic testing, and (5) a mechanism for reporting results. The most important program component is expert interpretation of genetic test results to provide clinically useful information; pharmacists are well positioned to provide that expertise. At the Northshore University HealthSystem pharmacogenomics clinic, patient encounters typically entail two one-hour visits and follow a standardized workflow. At the first visit, pharmacogenomics-focused medication and family histories are obtained, risks and benefits of genetic testing are explained, and a test sample is collected; at the second visit, test results are provided along with evidence-based pharmacotherapy recommendations. A multidisciplinary clinic providing genotyping and related services can facilitate the integration of pharmacogenomics into clinical care and meet the needs of early adopters of precision medicine. |
Audience | Academic |
Author | Hulick, Peter J Biszewski, Matthew Khandekar, Janardan Johnson, Samuel G Dunnenberger, Henry M May, Holley Sereika, Annette Bell, Gillian C |
Author_xml | – sequence: 1 givenname: Henry M surname: Dunnenberger fullname: Dunnenberger, Henry M email: mdunnenberger@northshore.org organization: Center for Molecular Medicine, NorthShore University HealthSystem, Evanston, IL. mdunnenberger@northshore.org – sequence: 2 givenname: Matthew surname: Biszewski fullname: Biszewski, Matthew organization: Thrombosis and Anticoagulation Unit, NorthShore University HealthSystem, Glenview, IL – sequence: 3 givenname: Gillian C surname: Bell fullname: Bell, Gillian C organization: Personalized Medicine, Mission Health, Asheville, NC – sequence: 4 givenname: Annette surname: Sereika fullname: Sereika, Annette organization: Center for Molecular Medicine, NorthShore University HealthSystem, Evanston, IL – sequence: 5 givenname: Holley surname: May fullname: May, Holley organization: Center for Medical Genetics, NorthShore University HealthSystem, Evanston, IL – sequence: 6 givenname: Samuel G surname: Johnson fullname: Johnson, Samuel G organization: Kaiser Permanente Colorado, Aurora, CO – sequence: 7 givenname: Peter J surname: Hulick fullname: Hulick, Peter J organization: Center for Medical Genetics, NorthShore University HealthSystem, Evanston, IL – sequence: 8 givenname: Janardan surname: Khandekar fullname: Khandekar, Janardan organization: Center for Molecular Medicine, NorthShore University HealthSystem, Evanston, IL |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27864203$$D View this record in MEDLINE/PubMed |
BookMark | eNqN0TtLxTAUB_Agiu_FDyAFFxGqeTVNR7n4AsFFF5eSpifeSJPUJh3utzdyfSA4SIaE5HfC4fz30KYPHhA6IvicEi4u1OtyJALjmm6gXVKxqqQNxpv5jOumpFjSHbQX4yvGhEosttEOraXgFLNd9HznxgEc-KSSDb4IplCFm4dkexu1HQfr1bQqxqWanNLhBXxwVsdC5werC-sz18G52du0KpaghrQs4iomcAdoy6ghwuHnvo-erq8eF7fl_cPN3eLyvtRM1qnkTU0qIQyWfcU1F1UtKeecdF1fVcowLDuQShADTPWaSNp0Upiuw6C4yZjto9P1v-MU3maIqXW5dRgG5SHMsSVSSMYpF-IflJO6ycMjmZ6s6YsaoLXehDQp_cHbSy4J5UwSntX5HyqvHvKYckzG5vtfBWfrAj2FGCcw7ThZl0fcEtx-pNn-pJnx8We7c-eg_6Zf8bF3x9SbZA |
CitedBy_id | crossref_primary_10_3389_fphar_2023_1274165 crossref_primary_10_1002_ajmg_c_31867 crossref_primary_10_1002_jac5_1699 crossref_primary_10_3390_jpm11050394 crossref_primary_10_2217_pgs_2019_0021 crossref_primary_10_2217_pgs_2018_0130 crossref_primary_10_1016_j_neuron_2021_09_011 crossref_primary_10_1093_ajhp_zxz024 crossref_primary_10_2147_PGPM_S314961 crossref_primary_10_3390_pharmacy11050144 crossref_primary_10_47671_TVG_77_21_035 crossref_primary_10_3390_genes10040276 crossref_primary_10_1007_s12687_021_00547_y crossref_primary_10_4140_TCP_n_2024_132 crossref_primary_10_2215_CJN_02730218 crossref_primary_10_3390_jpm12040599 crossref_primary_10_1002_jac5_1250 crossref_primary_10_1007_s11882_023_01087_w crossref_primary_10_1002_jac5_1570 crossref_primary_10_2217_pgs_2020_0168 crossref_primary_10_2146_ajhp170402 crossref_primary_10_1002_jac5_1447 crossref_primary_10_1016_j_japh_2023_04_022 crossref_primary_10_1080_23808993_2017_1398046 crossref_primary_10_1016_j_mayocp_2020_03_011 crossref_primary_10_1093_ajhp_zxac168 crossref_primary_10_2217_pgs_2018_0200 crossref_primary_10_3390_jpm12030425 crossref_primary_10_1097_j_pain_0000000000002637 crossref_primary_10_1111_cts_13154 crossref_primary_10_3390_jcm9072274 crossref_primary_10_3389_fgene_2023_1152585 crossref_primary_10_1071_PY18047 crossref_primary_10_1186_s40246_021_00361_0 crossref_primary_10_5496_wjmg_v11_i4_39 crossref_primary_10_2217_pgs_2021_0129 crossref_primary_10_2217_pme_2017_0032 crossref_primary_10_1016_j_sapharm_2021_08_009 crossref_primary_10_2217_pme_2017_0036 crossref_primary_10_2217_pme_2021_0061 crossref_primary_10_1016_j_mcpro_2024_100737 crossref_primary_10_3390_jpm12111821 crossref_primary_10_1016_j_japh_2020_11_005 crossref_primary_10_2217_pgs_2020_0076 crossref_primary_10_2147_PGPM_S241599 crossref_primary_10_2217_pgs_2023_0179 crossref_primary_10_2217_pgs_2017_0191 crossref_primary_10_1002_jac5_1118 crossref_primary_10_1002_jac5_1910 crossref_primary_10_3389_fphar_2024_1355412 crossref_primary_10_3389_fgene_2023_1308738 crossref_primary_10_3390_jpm11111051 crossref_primary_10_1002_cpt_600 crossref_primary_10_2217_pgs_2021_0044 crossref_primary_10_2147_PGPM_S224894 crossref_primary_10_1093_ajhp_zxy072 crossref_primary_10_2146_ajhp160104 crossref_primary_10_1055_a_1183_5029 crossref_primary_10_2217_pgs_2022_0013 crossref_primary_10_3389_fmed_2022_945352 crossref_primary_10_3390_pharmaceutics12121240 crossref_primary_10_1016_j_japh_2021_04_001 crossref_primary_10_1002_cpt_2387 crossref_primary_10_1093_ajhp_zxac189 crossref_primary_10_2217_pgs_2019_0198 crossref_primary_10_1016_j_psychres_2020_113649 crossref_primary_10_1093_ajhp_zxab137 crossref_primary_10_1093_ajhp_zxad159 crossref_primary_10_1002_jac5_1107 crossref_primary_10_2217_pgs_2020_0181 crossref_primary_10_1002_jac5_1868 crossref_primary_10_1177_1049732319858325 crossref_primary_10_1002_phar_1985 crossref_primary_10_1146_annurev_genom_111621_102737 crossref_primary_10_2217_pme_2018_0107 crossref_primary_10_2217_pgs_2021_0032 crossref_primary_10_1002_phar_1980 crossref_primary_10_3390_jpm9030040 crossref_primary_10_3390_jpm10040154 crossref_primary_10_3390_pharmacy6040115 crossref_primary_10_3390_jpm12081313 crossref_primary_10_1016_j_mcna_2019_07_002 crossref_primary_10_5688_ajpe8634 crossref_primary_10_1002_jac5_1381 crossref_primary_10_1002_jac5_1341 crossref_primary_10_1007_s11095_017_2163_x crossref_primary_10_3390_jpm11121296 |
Cites_doi | 10.1007/978-1-62703-435-7_20 10.1331/JAPhA.2015.15017 10.1038/clpt.2014.97 10.1331/JAPhA.2011.11543 10.2217/pgs.12.176 10.1038/clpt.2013.105 10.1038/clpt.2013.2 10.1146/annurev-genom-090413-025419 10.2217/pgs.15.124 10.1038/clpt.2013.72 10.1038/clpt.2013.254 10.1097/FPC.0000000000000028 10.1146/annurev-pharmtox-010814-124835 10.1089/gtmb.2012.0165 10.1038/clpt.2013.229 10.2217/pme.13.85 10.1038/clpt.2011.306 10.1038/clpt.2014.137 10.1038/clpt.2011.34 10.1038/clpt.2013.52 10.1038/clpt.2011.185 10.1038/clpt.2011.287 10.1038/clpt.2013.103 10.1097/GIM.0b013e318238b38c 10.1331/JAPhA.2014.13041 10.1038/clpt.2012.209 10.1177/0897190014522496 10.1016/S1470-2045(10)70097-8 10.5688/ajpe75351 10.1038/clpt.2012.125 10.1093/jac/dkv224 10.1002/cpt.269 10.1038/clpt.2011.355 10.1002/ajmg.c.31391 10.1007/s10897-011-9415-4 10.1038/clpt.2010.279 10.1038/clpt.2013.203 10.1002/phar.1481 10.2217/pgs.13.76 10.1002/cpt.113 10.2217/fca.15.20 10.1331/JAPhA.2008.07050 10.1111/j.1399-0004.2012.01848.x 10.1038/clpt.2012.117 10.1002/ajmg.c.31396 10.1002/cpt.147 10.1038/clpt.2012.57 10.1038/clpt.2014.125 10.1038/clpt.2010.320 10.1038/clpt.2014.54 10.1038/sj.clpt.6100507 10.1038/clpt.2014.159 10.1331/JAPhA.2011.10178 10.1002/phar.1329 10.2217/pgs.13.52 10.2146/sp150003 10.2217/pgs.13.77 10.1038/tpj.2011.1 10.1016/j.mayocp.2013.10.021 10.1038/clpt.2013.172 10.1038/clpt.2011.371 10.1136/amiajnl-2013-001993 10.1038/clpt.2013.59 10.1038/clpt.2011.132 10.1002/ajmg.c.31390 10.1038/clpt.2014.101 10.2217/pgs.14.109 10.2217/pgs.14.173 10.1016/j.ijmedinf.2015.11.015 10.1038/clpt.2013.4 10.1038/clpt.2011.187 10.1038/clpt.2014.38 |
ContentType | Journal Article |
Copyright | Copyright © 2016 by the American Society of Health-System Pharmacists, Inc. All rights reserved. COPYRIGHT 2016 Oxford University Press |
Copyright_xml | – notice: Copyright © 2016 by the American Society of Health-System Pharmacists, Inc. All rights reserved. – notice: COPYRIGHT 2016 Oxford University Press |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 7QO 8FD FR3 P64 |
DOI | 10.2146/ajhp160072 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic Biotechnology Research Abstracts Technology Research Database Engineering Research Database Biotechnology and BioEngineering Abstracts |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic Engineering Research Database Biotechnology Research Abstracts Technology Research Database Biotechnology and BioEngineering Abstracts |
DatabaseTitleList | Engineering Research Database MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Public Health Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1535-2900 |
EndPage | 1966 |
ExternalDocumentID | A481243814 10_2146_ajhp160072 27864203 |
Genre | Journal Article Review |
GeographicLocations | United States |
GeographicLocations_xml | – name: United States |
GroupedDBID | --- .XZ 04C 0R~ 23M 36B 4.4 48X 5GY 5RE 5RS 5WD 6J9 6PF AABZA AACZT AAIMJ AAPQZ AAPXW AARHZ AAUAY AAVAP AAWTL AAYEP AAYOK ABCQX ABDBF ABJNI ABMNT ABNHQ ABPQP ABPTD ABQNK ABWST ABXVV ACFRR ACGFO ACIWK ACPRK ACYHN ADBBV ADGKP ADGZP ADIPN ADOJX ADQBN ADRTK ADVEK AEGXH AELWJ AENEX AETBJ AFFZL AFGWE AFRAH AFXAL AGINJ AGQXC AGUTN AIAGR AJEEA ALMA_UNASSIGNED_HOLDINGS ATGXG BCRHZ BEYMZ BMSDO C45 CGR CS3 CUY CVF EAD EAP EAS EBC EBD EBS ECF ECM ECT ECV EHN EIF EIHBH EJD EMB EMK EMOBN ENC ENERS EPL EPT EST ESX EX3 F5P FECEO FHSFR FLUFQ FOEOM FOTVD FQBLK GAUVT H13 IAO IHR INH INR ITC J5H KBUDW KOP KSI KSN L7B M5~ MHKGH MK0 MV1 NLBLG NOMLY NOYVH NPM NVLIB O9- OAUYM OB4 OBOKY OCZFY ODMLO OFXIZ OJZSN OPAEJ OVD OVIDX OWPYF P2P PONUX PV9 Q~Q R0Z RHI ROX RUSNO RZL SJN SV3 TEORI TMA TSH TUS VVN WH7 WOW WQ9 YFH YOC YXANX AASNB AAYXX CITATION ABEJV 7X8 7QO 8FD FR3 P64 |
ID | FETCH-LOGICAL-c387t-4971566f08d54c4657824441bbd55af308be8a61fe3adc1829b86fbb0ea4f5783 |
ISSN | 1079-2082 |
IngestDate | Fri Oct 25 09:26:56 EDT 2024 Fri Oct 25 22:03:52 EDT 2024 Tue Nov 19 21:24:27 EST 2024 Tue Nov 12 23:14:39 EST 2024 Thu Sep 26 19:11:19 EDT 2024 Wed Oct 16 00:50:12 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 23 |
Keywords | clinical implementation precision medicine medication therapy management pharmacogenomics comprehensive medication management pharmacogenetics |
Language | English |
License | Copyright © 2016 by the American Society of Health-System Pharmacists, Inc. All rights reserved. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c387t-4971566f08d54c4657824441bbd55af308be8a61fe3adc1829b86fbb0ea4f5783 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 ObjectType-Article-1 ObjectType-Feature-2 |
PMID | 27864203 |
PQID | 1841799001 |
PQPubID | 23479 |
PageCount | 11 |
ParticipantIDs | proquest_miscellaneous_1868342466 proquest_miscellaneous_1841799001 gale_infotracmisc_A481243814 gale_infotracacademiconefile_A481243814 crossref_primary_10_2146_ajhp160072 pubmed_primary_27864203 |
PublicationCentury | 2000 |
PublicationDate | 2016-Dec-01 2016-12-01 20161201 |
PublicationDateYYYYMMDD | 2016-12-01 |
PublicationDate_xml | – month: 12 year: 2016 text: 2016-Dec-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | American journal of health-system pharmacy |
PublicationTitleAlternate | Am J Health Syst Pharm |
PublicationYear | 2016 |
Publisher | Oxford University Press |
Publisher_xml | – name: Oxford University Press |
References | Gottesman ( key 2019041103115124000_b24-0731956) 2013; 94 Hicks ( key 2019041103115124000_b52-0731956) 2013; 93 Cavallari ( key 2019041103115124000_b74-0731956) 2015; 11 Hicks ( key 2019041103115124000_b54-0731956) 2015; 98 Stanek ( key 2019041103115124000_b16-0731956) 2012; 91 Haga ( key 2019041103115124000_b35-0731956) 2015; 16 Romagnoli ( key 2019041103115124000_b72-0731956) 2016; 86 McBane ( key 2019041103115124000_b79-0731956) 2015; 35 Hoffman ( key 2019041103115124000_b21-0731956) 2014; 166C McCullough ( key 2019041103115124000_b14-0731956) 2011; 75 Crews ( key 2019041103115124000_b62-0731956) 2012; 91 Pereira ( key 2019041103115124000_b5-0731956) 2011; 90 Weitzel ( key 2019041103115124000_b26-0731956) 2016; 9 Rubinstein ( key 2019041103115124000_b44-0731956) 2013; 41 Kennedy ( key 2019041103115124000_b77-0731956) 2011; 16 Leckband ( key 2019041103115124000_b65-0731956) 2013; 94 Eliasson ( key 2019041103115124000_b18-0731956) 2012; 13 Scott ( key 2019041103115124000_b64-0731956) 2013; 94 Van Driest ( key 2019041103115124000_b42-0731956) 2014; 95 Kuo ( key 2019041103115124000_b73-0731956) 2013; 14 El-Ibiary ( key 2019041103115124000_b75-0731956) 2008; 48 Thorn ( key 2019041103115124000_b47-0731956) 2013; 1015 Haga ( key 2019041103115124000_b12-0731956) 2012; 12 Scott ( key 2019041103115124000_b63-0731956) 2011; 90 Haga ( key 2019041103115124000_b34-0731956) 2014; 15 Callard ( key 2019041103115124000_b36-0731956) 2012; 21 Mills ( key 2019041103115124000_b37-0731956) 2013; 14 Tuteja ( key 2019041103115124000_b15-0731956) 2013; 10 Shuldiner ( key 2019041103115124000_b25-0731956) 2014; 166C Bielinski ( key 2019041103115124000_b23-0731956) 2014; 89 Crews ( key 2019041103115124000_b45-0731956) 2014; 95 Muir ( key 2019041103115124000_b59-0731956) 2014; 95 Kisor ( key 2019041103115124000_b31-0731956) 2014; 27 Reinke ( key 2019041103115124000_b32-0731956) 2014; 23 Weitzel ( key 2019041103115124000_b22-0731956) 2014; 166C Relling ( key 2019041103115124000_b51-0731956) 2011; 89 Relling ( key 2019041103115124000_b57-0731956) 2014; 96 Pulley ( key 2019041103115124000_b20-0731956) 2012; 92 Levy ( key 2019041103115124000_b11-0731956) 2014; 96 Dunnenberger ( key 2019041103115124000_b43-0731956) 2015; 55 Relling ( key 2019041103115124000_b49-0731956) 2013; 93 Haga ( key 2019041103115124000_b33-0731956) 2015; 16 Relling ( key 2019041103115124000_b9-0731956) 2010; 11 Gammal ( key 2019041103115124000_b66-0731956) 2015; 99 Moaddeb ( key 2019041103115124000_b28-0731956) 2015; 55 Owusu-Obeng ( key 2019041103115124000_b76-0731956) 2014; 34 Pirmohamed ( key 2019041103115124000_b3-0731956) 2014; 15 Clancy ( key 2019041103115124000_b60-0731956) 2014; 95 Martin ( key 2019041103115124000_b69-0731956) 2014; 95 O’Donnell ( key 2019041103115124000_b19-0731956) 2012; 92 Farrugia ( key 2019041103115124000_b7-0731956) 2013; 94 Crews ( key 2019041103115124000_b1-0731956) 2012; 92 Rasmussen-Torvik ( key 2019041103115124000_b27-0731956) 2014; 96 American Society of Health-System Pharmacists ( key 2019041103115124000_b39-0731956) 2015; 72 key 2019041103115124000_b46-0731956 Martin ( key 2019041103115124000_b68-0731956) 2012; 91 Johnson ( key 2019041103115124000_b6-0731956) 2012; 92 Nutescu ( key 2019041103115124000_b40-0731956) 2013; 33 Reiss ( key 2019041103115124000_b78-0731956) 2011; 51 Haga ( key 2019041103115124000_b38-0731956) 2014; 24 Wilke ( key 2019041103115124000_b55-0731956) 2012; 92 Mason ( key 2019041103115124000_b2-0731956) 2015; 70 Relling ( key 2019041103115124000_b48-0731956) 2011; 89 Ramsey ( key 2019041103115124000_b56-0731956) 2014; 96 Caudle ( key 2019041103115124000_b58-0731956) 2014; 96 Shuldiner ( key 2019041103115124000_b4-0731956) 2013; 94 Birdwell ( key 2019041103115124000_b53-0731956) 2015; 98 Bell ( key 2019041103115124000_b41-0731956) 2014; 21 Johnson ( key 2019041103115124000_b50-0731956) 2011; 90 Scott ( key 2019041103115124000_b10-0731956) 2011; 13 Caudle ( key 2019041103115124000_b61-0731956) 2013; 94 Swen ( key 2019041103115124000_b70-0731956) 2011; 89 Johnson ( key 2019041103115124000_b8-0731956) 2013; 14 Haga ( key 2019041103115124000_b13-0731956) 2012; 82 Selkirk ( key 2019041103115124000_b17-0731956) 2013; 17 Padgett ( key 2019041103115124000_b30-0731956) 2011; 51 Alexander ( key 2019041103115124000_b29-0731956) 2014; 54 Hershfield ( key 2019041103115124000_b67-0731956) 2013; 93 Swen ( key 2019041103115124000_b71-0731956) 2008; 83 |
References_xml | – volume: 1015 start-page: 311 year: 2013 ident: key 2019041103115124000_b47-0731956 article-title: PharmGKB: the Pharmacogenomics Knowledge Base publication-title: Meth Mol Biol doi: 10.1007/978-1-62703-435-7_20 contributor: fullname: Thorn – volume: 55 start-page: e435 year: 2015 ident: key 2019041103115124000_b28-0731956 article-title: Community pharmacists’ experience with pharmacogenetic testing publication-title: J Am Pharm Assoc doi: 10.1331/JAPhA.2015.15017 contributor: fullname: Moaddeb – volume: 16 start-page: 118 year: 2011 ident: key 2019041103115124000_b77-0731956 article-title: The role of the pediatric pharmacist in personalized medicine and clinical pharmacogenomics for children: pediatric pharmacogenomics working group publication-title: J Pediatr Pharmacol Ther contributor: fullname: Kennedy – volume: 96 start-page: 169 year: 2014 ident: key 2019041103115124000_b57-0731956 article-title: Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for rasburicase therapy in the context of G6PD deficiency genotype publication-title: Clin Pharmacol Ther doi: 10.1038/clpt.2014.97 contributor: fullname: Relling – volume: 51 start-page: e64 year: 2011 ident: key 2019041103115124000_b78-0731956 article-title: Integrating pharmacogenomics into pharmacy practice via medication therapy management publication-title: J Am Pharm Assoc doi: 10.1331/JAPhA.2011.11543 contributor: fullname: Reiss – volume: 13 start-page: 1887 year: 2012 ident: key 2019041103115124000_b18-0731956 article-title: Institutional profile: Karolinska Institutet publication-title: Pharmacogenomics doi: 10.2217/pgs.12.176 contributor: fullname: Eliasson – volume: 94 start-page: 317 year: 2013 ident: key 2019041103115124000_b64-0731956 article-title: Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update publication-title: Clin Pharmacol Ther doi: 10.1038/clpt.2013.105 contributor: fullname: Scott – volume: 93 start-page: 402 year: 2013 ident: key 2019041103115124000_b52-0731956 article-title: Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants publication-title: Clin Pharmacol Ther doi: 10.1038/clpt.2013.2 contributor: fullname: Hicks – volume: 15 start-page: 349 year: 2014 ident: key 2019041103115124000_b3-0731956 article-title: Personalized pharmacogenomics: predicting efficacy and adverse drug reactions publication-title: Annu Rev Genomics Hum Genet doi: 10.1146/annurev-genom-090413-025419 contributor: fullname: Pirmohamed – volume: 16 start-page: 1931 year: 2015 ident: key 2019041103115124000_b33-0731956 article-title: Incorporation of pharmacogenetic testing into medication therapy management publication-title: Pharmacogenomics doi: 10.2217/pgs.15.124 contributor: fullname: Haga – volume: 94 start-page: 214 year: 2013 ident: key 2019041103115124000_b24-0731956 article-title: The CLIPMERGE PGx Program: clinical implementation of personalized medicine through electronic health records and genomics-pharmacogenomics publication-title: Clin Pharmacol Ther doi: 10.1038/clpt.2013.72 contributor: fullname: Gottesman – volume: 95 start-page: 376 year: 2014 ident: key 2019041103115124000_b45-0731956 article-title: Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update publication-title: Clin Pharmacol Ther doi: 10.1038/clpt.2013.254 contributor: fullname: Crews – volume: 24 start-page: 139 year: 2014 ident: key 2019041103115124000_b38-0731956 article-title: Comparison of delivery strategies for pharmacogenetic testing services publication-title: Pharmacogenet Genomics doi: 10.1097/FPC.0000000000000028 contributor: fullname: Haga – volume: 55 start-page: 89 year: 2015 ident: key 2019041103115124000_b43-0731956 article-title: Preemptive clinical pharmacogenetics implementation: current programs in five United States medical centers publication-title: Annu Rev Pharmacol Toxicol doi: 10.1146/annurev-pharmtox-010814-124835 contributor: fullname: Dunnenberger – volume: 17 start-page: 219 year: 2013 ident: key 2019041103115124000_b17-0731956 article-title: Physicians’ preparedness for integration of genomic and pharmacogenetic testing into practice within a major healthcare system publication-title: Genet Test Mol Biomarkers doi: 10.1089/gtmb.2012.0165 contributor: fullname: Selkirk – volume: 95 start-page: 423 year: 2014 ident: key 2019041103115124000_b42-0731956 article-title: Clinically actionable genotypes among 10,000 patients with preemptive pharmacogenomic testing publication-title: Clin Pharmacol Ther doi: 10.1038/clpt.2013.229 contributor: fullname: Van Driest – volume: 10 start-page: 793 year: 2013 ident: key 2019041103115124000_b15-0731956 article-title: Community pharmacists’ attitudes towards clinical utility and ethical implications of pharmacogenetic testing publication-title: Per Med doi: 10.2217/pme.13.85 contributor: fullname: Tuteja – volume: 91 start-page: 450 year: 2012 ident: key 2019041103115124000_b16-0731956 article-title: Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey publication-title: Clin Pharmacol Ther doi: 10.1038/clpt.2011.306 contributor: fullname: Stanek – volume: 96 start-page: 482 year: 2014 ident: key 2019041103115124000_b27-0731956 article-title: Design and anticipated outcomes of the eMERGE-PGx Project: a multicenter pilot for preemptive pharmacogenomics in electronic health record systems publication-title: Clin Pharmacol Ther doi: 10.1038/clpt.2014.137 contributor: fullname: Rasmussen-Torvik – volume: 89 start-page: 662 year: 2011 ident: key 2019041103115124000_b70-0731956 article-title: Pharmacogenetics: from bench to byte—an update of guidelines publication-title: Clin Pharmacol Ther doi: 10.1038/clpt.2011.34 contributor: fullname: Swen – volume: 94 start-page: 204 year: 2013 ident: key 2019041103115124000_b7-0731956 article-title: Challenges in implementing genomic medicine: the Mayo Clinic Center for Individualized Medicine publication-title: Clin Pharmacol Ther doi: 10.1038/clpt.2013.52 contributor: fullname: Farrugia – volume: 35 start-page: e39 year: 2015 ident: key 2019041103115124000_b79-0731956 article-title: Collaborative drug therapy management and comprehensive medication management—2015 publication-title: Pharmacotherapy contributor: fullname: McBane – volume: 90 start-page: 625 year: 2011 ident: key 2019041103115124000_b50-0731956 article-title: Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing publication-title: Clin Pharmacol Ther doi: 10.1038/clpt.2011.185 contributor: fullname: Johnson – volume: 91 start-page: 321 year: 2012 ident: key 2019041103115124000_b62-0731956 article-title: Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotype publication-title: Clin Pharmacol Ther doi: 10.1038/clpt.2011.287 contributor: fullname: Crews – volume: 94 start-page: 324 year: 2013 ident: key 2019041103115124000_b65-0731956 article-title: Clinical Pharmacogenetics Implementation Consortium guidelines for HLA-B genotype and carbamazepine dosing publication-title: Clin Pharmacol Ther doi: 10.1038/clpt.2013.103 contributor: fullname: Leckband – volume: 13 start-page: 987 year: 2011 ident: key 2019041103115124000_b10-0731956 article-title: Personalizing medicine with clinical pharmacogenetics publication-title: Genet Med doi: 10.1097/GIM.0b013e318238b38c contributor: fullname: Scott – volume: 54 start-page: 510 year: 2014 ident: key 2019041103115124000_b29-0731956 article-title: Implementation of personalized medicine services in community pharmacies: perceptions of independent community pharmacists publication-title: J Am Pharm Assoc doi: 10.1331/JAPhA.2014.13041 contributor: fullname: Alexander – volume: 93 start-page: 153 year: 2013 ident: key 2019041103115124000_b67-0731956 article-title: Clinical Pharmacogenetics Implementation Consortium guidelines for human leukocyte antigen-B genotype and allopurinol dosing publication-title: Clin Pharmacol Ther doi: 10.1038/clpt.2012.209 contributor: fullname: Hershfield – volume: 27 start-page: 416 year: 2014 ident: key 2019041103115124000_b31-0731956 article-title: Pharmacogenetics in the community pharmacy: thienopyridine selection post-coronary artery stent placement publication-title: J Pharm Pract doi: 10.1177/0897190014522496 contributor: fullname: Kisor – volume: 11 start-page: 507 year: 2010 ident: key 2019041103115124000_b9-0731956 article-title: Clinical implementation of pharmacogenomics: overcoming genetic exceptionalism publication-title: Lancet Oncol doi: 10.1016/S1470-2045(10)70097-8 contributor: fullname: Relling – ident: key 2019041103115124000_b46-0731956 – volume: 75 year: 2011 ident: key 2019041103115124000_b14-0731956 article-title: Assessment of the pharmacogenomics educational needs of pharmacists publication-title: Am J Pharm Educ doi: 10.5688/ajpe75351 contributor: fullname: McCullough – volume: 92 start-page: 437 year: 2012 ident: key 2019041103115124000_b6-0731956 article-title: Implementing personalized medicine: development of a cost-effective customized pharmacogenetics genotyping array publication-title: Clin Pharmacol Ther doi: 10.1038/clpt.2012.125 contributor: fullname: Johnson – volume: 70 start-page: 3124 year: 2015 ident: key 2019041103115124000_b2-0731956 article-title: Budget impact analysis of CYP2C19-guided voriconazole prophylaxis in AML publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkv224 contributor: fullname: Mason – volume: 99 start-page: 363 year: 2015 ident: key 2019041103115124000_b66-0731956 article-title: Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for UGT1A1 and atazanavir prescribing publication-title: Clin Pharmacol Ther doi: 10.1002/cpt.269 contributor: fullname: Gammal – volume: 91 start-page: 734 year: 2012 ident: key 2019041103115124000_b68-0731956 article-title: Clinical Pharmacogenetics Implementation Consortium guidelines for HLA-B genotype and abacavir dosing publication-title: Clin Pharmacol Ther doi: 10.1038/clpt.2011.355 contributor: fullname: Martin – volume: 166C start-page: 45 issue: suppl 1 year: 2014 ident: key 2019041103115124000_b21-0731956 article-title: PG4KDS: a model for the clinical implementation of preemptive pharmacogenetics publication-title: Am J Med Genet C Semin Med Genet doi: 10.1002/ajmg.c.31391 contributor: fullname: Hoffman – volume: 41 start-page: D925 issue: database issue year: 2013 ident: key 2019041103115124000_b44-0731956 article-title: The NIH genetic testing registry: a new, centralized database of genetic tests to enable access to comprehensive information and improve transparency publication-title: Nucleic Acids Res contributor: fullname: Rubinstein – volume: 21 start-page: 527 year: 2012 ident: key 2019041103115124000_b36-0731956 article-title: Delivering a pharmacogenetic service: is there a role for genetic counselors? publication-title: J Genet Couns doi: 10.1007/s10897-011-9415-4 contributor: fullname: Callard – volume: 89 start-page: 464 year: 2011 ident: key 2019041103115124000_b48-0731956 article-title: CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network publication-title: Clin Pharmacol Ther doi: 10.1038/clpt.2010.279 contributor: fullname: Relling – volume: 95 start-page: 141 year: 2014 ident: key 2019041103115124000_b59-0731956 article-title: Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for IFNL3 (IL28B) genotype and PEG interferon-alpha-based regimens publication-title: Clin Pharmacol Ther doi: 10.1038/clpt.2013.203 contributor: fullname: Muir – volume: 34 start-page: 1102 year: 2014 ident: key 2019041103115124000_b76-0731956 article-title: Emerging roles for pharmacists in clinical implementation of pharmacogenomics publication-title: Pharmacotherapy doi: 10.1002/phar.1481 contributor: fullname: Owusu-Obeng – volume: 14 start-page: 957 year: 2013 ident: key 2019041103115124000_b37-0731956 article-title: Clinical delivery of pharmacogenetic testing services: a proposed partnership between genetic counselors and pharmacists publication-title: Pharmacogenomics doi: 10.2217/pgs.13.76 contributor: fullname: Mills – volume: 98 start-page: 19 year: 2015 ident: key 2019041103115124000_b53-0731956 article-title: Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for CYP3A5 genotype and tacrolimus dosing publication-title: Clin Pharmacol Ther doi: 10.1002/cpt.113 contributor: fullname: Birdwell – volume: 11 start-page: 281 year: 2015 ident: key 2019041103115124000_b74-0731956 article-title: Pharmacogenomics in cardiology—genetics and drug response: 10 years of progress publication-title: Future Cardiol doi: 10.2217/fca.15.20 contributor: fullname: Cavallari – volume: 48 start-page: e21 year: 2008 ident: key 2019041103115124000_b75-0731956 article-title: Potential roles for pharmacists in pharmacogenetics publication-title: J Am Pharm Assoc doi: 10.1331/JAPhA.2008.07050 contributor: fullname: El-Ibiary – volume: 82 start-page: 115 year: 2012 ident: key 2019041103115124000_b13-0731956 article-title: Survey of genetic counselors and clinical geneticists’ use and attitudes toward pharmacogenetic testing publication-title: Clin Genet doi: 10.1111/j.1399-0004.2012.01848.x contributor: fullname: Haga – volume: 92 start-page: 446 year: 2012 ident: key 2019041103115124000_b19-0731956 article-title: The 1200 Patients Project: creating a new medical model system for clinical implementation of pharmacogenomics publication-title: Clin Pharmacol Ther doi: 10.1038/clpt.2012.117 contributor: fullname: O’Donnell – volume: 166C start-page: 76 issue: suppl 1 year: 2014 ident: key 2019041103115124000_b25-0731956 article-title: Implementation of pharmacogenetics: the University of Maryland Personalized Anti-platelet Pharmacogenetics Program publication-title: Am J Med Genet C Semin Med Genet doi: 10.1002/ajmg.c.31396 contributor: fullname: Shuldiner – volume: 92 start-page: 467 year: 2012 ident: key 2019041103115124000_b1-0731956 article-title: Pharmacogenomics and individualized medicine: translating science into practice publication-title: Clin Pharmacol Ther contributor: fullname: Crews – volume: 98 start-page: 127 year: 2015 ident: key 2019041103115124000_b54-0731956 article-title: Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 and CYP2C19 genotypes and dosing of selective serotonin reuptake inhibitors publication-title: Clin Pharmacol Ther doi: 10.1002/cpt.147 contributor: fullname: Hicks – volume: 92 start-page: 112 year: 2012 ident: key 2019041103115124000_b55-0731956 article-title: The Clinical Pharmacogenetics Implementation Consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy publication-title: Clin Pharmacol Ther doi: 10.1038/clpt.2012.57 contributor: fullname: Wilke – volume: 96 start-page: 423 year: 2014 ident: key 2019041103115124000_b56-0731956 article-title: The Clinical Pharmacogenetics Implementation Consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update publication-title: Clin Pharmacol Ther doi: 10.1038/clpt.2014.125 contributor: fullname: Ramsey – volume: 89 start-page: 387 year: 2011 ident: key 2019041103115124000_b51-0731956 article-title: Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing publication-title: Clin Pharmacol Ther doi: 10.1038/clpt.2010.320 contributor: fullname: Relling – volume: 95 start-page: 592 year: 2014 ident: key 2019041103115124000_b60-0731956 article-title: Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for ivacaftor therapy in the context of CFTR genotype publication-title: Clin Pharmacol Ther doi: 10.1038/clpt.2014.54 contributor: fullname: Clancy – volume: 83 start-page: 781 year: 2008 ident: key 2019041103115124000_b71-0731956 article-title: Pharmacogenetics: from bench to byte publication-title: Clin Pharmacol Ther doi: 10.1038/sj.clpt.6100507 contributor: fullname: Swen – volume: 96 start-page: 542 year: 2014 ident: key 2019041103115124000_b58-0731956 article-title: Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C9 and HLA-B genotypes and phenytoin dosing publication-title: Clin Pharmacol Ther doi: 10.1038/clpt.2014.159 contributor: fullname: Caudle – volume: 51 start-page: 189 year: 2011 ident: key 2019041103115124000_b30-0731956 article-title: Pharmacogenomics in a community pharmacy: ACT now publication-title: J Am Pharm Assoc doi: 10.1331/JAPhA.2011.10178 contributor: fullname: Padgett – volume: 33 start-page: 1156 year: 2013 ident: key 2019041103115124000_b40-0731956 article-title: Feasibility of implementing a comprehensive warfarin pharmacogenetics service publication-title: Pharmacotherapy doi: 10.1002/phar.1329 contributor: fullname: Nutescu – volume: 14 start-page: 835 year: 2013 ident: key 2019041103115124000_b8-0731956 article-title: Pharmacogenetics in clinical practice: how far have we come and where are we going? publication-title: Pharmacogenomics doi: 10.2217/pgs.13.52 contributor: fullname: Johnson – volume: 72 start-page: 579 year: 2015 ident: key 2019041103115124000_b39-0731956 article-title: ASHP statement on the pharmacist’s role in clinical pharmacogenomics publication-title: Am J Health-Syst Pharm doi: 10.2146/sp150003 contributor: fullname: American Society of Health-System Pharmacists – volume: 14 start-page: 885 year: 2013 ident: key 2019041103115124000_b73-0731956 article-title: Implementation and outcomes of a live continuing education program on pharmacogenomics publication-title: Pharmacogenomics doi: 10.2217/pgs.13.77 contributor: fullname: Kuo – volume: 12 start-page: 197 year: 2012 ident: key 2019041103115124000_b12-0731956 article-title: Survey of US public attitudes toward pharmacogenetic testing publication-title: Pharmacogenomics J doi: 10.1038/tpj.2011.1 contributor: fullname: Haga – volume: 89 start-page: 25 year: 2014 ident: key 2019041103115124000_b23-0731956 article-title: Preemptive genotyping for personalized medicine: design of the right drug, right dose, right time—using genomic data to individualize treatment protocol publication-title: Mayo Clin Proc doi: 10.1016/j.mayocp.2013.10.021 contributor: fullname: Bielinski – volume: 94 start-page: 640 year: 2013 ident: key 2019041103115124000_b61-0731956 article-title: Clinical Pharmacogenetics Implementation Consortium guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing publication-title: Clin Pharmacol Ther doi: 10.1038/clpt.2013.172 contributor: fullname: Caudle – volume: 92 start-page: 87 year: 2012 ident: key 2019041103115124000_b20-0731956 article-title: Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT project publication-title: Clin Pharmacol Ther doi: 10.1038/clpt.2011.371 contributor: fullname: Pulley – volume: 21 start-page: e93 issue: e1 year: 2014 ident: key 2019041103115124000_b41-0731956 article-title: Development and use of active clinical decision support for preemptive pharmacogenomics publication-title: J Am Med Inform Assoc doi: 10.1136/amiajnl-2013-001993 contributor: fullname: Bell – volume: 94 start-page: 207 year: 2013 ident: key 2019041103115124000_b4-0731956 article-title: The Pharmacogenomics Research Network Translational Pharmacogenetics Program: overcoming challenges of real-world implementation publication-title: Clin Pharmacol Ther doi: 10.1038/clpt.2013.59 contributor: fullname: Shuldiner – volume: 90 start-page: 328 year: 2011 ident: key 2019041103115124000_b63-0731956 article-title: Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450-2C19 (CYP2C19) genotype and clopidogrel therapy publication-title: Clin Pharmacol Ther doi: 10.1038/clpt.2011.132 contributor: fullname: Scott – volume: 23 start-page: 6 issue: 10 year: 2014 ident: key 2019041103115124000_b32-0731956 article-title: Pharmacists experiment with pharmacogenomic management publication-title: Manag Care contributor: fullname: Reinke – volume: 166C start-page: 56 issue: suppl 1 year: 2014 ident: key 2019041103115124000_b22-0731956 article-title: Clinical pharmacogenetics implementation: approaches, successes, and challenges publication-title: Am J Med Genet C Semin Med Genet doi: 10.1002/ajmg.c.31390 contributor: fullname: Weitzel – volume: 96 start-page: 307 year: 2014 ident: key 2019041103115124000_b11-0731956 article-title: Prerequisites to implementing a pharmacogenomics program in a large healthcare system publication-title: Clin Pharmacol Ther doi: 10.1038/clpt.2014.101 contributor: fullname: Levy – volume: 15 start-page: 1677 year: 2014 ident: key 2019041103115124000_b34-0731956 article-title: Pilot study of pharmacist-assisted delivery of pharmacogenetic testing in a primary care setting publication-title: Pharmacogenomics doi: 10.2217/pgs.14.109 contributor: fullname: Haga – volume: 9 start-page: 1 year: 2016 ident: key 2019041103115124000_b26-0731956 article-title: The IGNITE network: a model for genomic medicine implementation and research publication-title: BMC Med Genet contributor: fullname: Weitzel – volume: 16 start-page: 251 year: 2015 ident: key 2019041103115124000_b35-0731956 article-title: Nurses’ communication of pharmacogenetic test results as part of discharge care publication-title: Pharmacogenomics doi: 10.2217/pgs.14.173 contributor: fullname: Haga – volume: 86 start-page: 54 year: 2016 ident: key 2019041103115124000_b72-0731956 article-title: Bringing clinical pharmacogenomics information to pharmacists: a qualitative study of information needs and resource requirements publication-title: Int J Med Inform doi: 10.1016/j.ijmedinf.2015.11.015 contributor: fullname: Romagnoli – volume: 93 start-page: 324 year: 2013 ident: key 2019041103115124000_b49-0731956 article-title: Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing: 2013 update publication-title: Clin Pharmacol Ther doi: 10.1038/clpt.2013.4 contributor: fullname: Relling – volume: 90 start-page: 493 year: 2011 ident: key 2019041103115124000_b5-0731956 article-title: The impact of pharmacogenomics on the management of cardiac disease publication-title: Clin Pharmacol Ther doi: 10.1038/clpt.2011.187 contributor: fullname: Pereira – volume: 95 start-page: 499 year: 2014 ident: key 2019041103115124000_b69-0731956 article-title: Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B genotype and abacavir dosing: 2014 update publication-title: Clin Pharmacol Ther doi: 10.1038/clpt.2014.38 contributor: fullname: Martin |
SSID | ssj0012806 |
Score | 2.5062401 |
SecondaryResourceType | review_article |
Snippet | The development and implementation of a multidisciplinary pharmacogenomics clinic within the framework of an established community-based medical genetics... Purpose. The development and implementation of a multidisciplinary pharmacogenomics clinic within the framework of an established community-based medical... PURPOSEThe development and implementation of a multidisciplinary pharmacogenomics clinic within the framework of an established community-based medical... PurposeThe development and implementation of a multidisciplinary pharmacogenomics clinic within the framework of an established community-based medical... |
SourceID | proquest gale crossref pubmed |
SourceType | Aggregation Database Index Database |
StartPage | 1956 |
SubjectTerms | Community Health Planning - methods Community Health Planning - trends Community health services Community Pharmacy Services - trends Genetic Testing - methods Genetic Testing - trends Humans Management Patient Care Team - trends Pharmacogenetics - methods Pharmacogenetics - trends Pharmacogenomics Precision medicine Precision Medicine - methods Precision Medicine - trends Professional Role |
Title | Implementation of a multidisciplinary pharmacogenomics clinic in a community health system |
URI | https://www.ncbi.nlm.nih.gov/pubmed/27864203 https://search.proquest.com/docview/1841799001 https://search.proquest.com/docview/1868342466 |
Volume | 73 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELa22wsSqqC8thRkBCqXRsrT8R63sIVDVSqRVisukeM4YkHNrvZxgF_PTMZ5LQiVAxdrZXuTKDMZj8fzfcPYmwwXTZPlDnyE0MQ6d5TU2pESUZVxWERFFbr4HF_O5PtpOB0M6lB62_dfJQ19IGtEzv6DtJuLQgf8BplDC1KH9k5yr-h-by2iqCT4Y5U12MPfLi1jNVK03iJRMyEkMfqhMM0cQSPgnhNK0tI9d_3Y5qCnwzxBkx2aXN-hidijp0zZZKQkFTqijcWezdc_wd5SEW1bhLwZs2cjH6rYUNkJ7JqVmX-nyDDCi2zSkg1ieKKTEEJ2143HIEbZM8xU48QqoB90zCyCHDtLNlgR8aflwLc8yN--Lj3k4ffbRa8-6L_8lJ5fX1ykyXSW7LF9H8xVNGT7k7PZzU1zGoWnz5S7Sg9JNLd-VSyouXbPsdld3nc2LZXzkjxgB3bXwSekLg_ZwJSH7OTKiuiUJy0Kb33KT_hVS2j-45Ddp9guJ8jaI_alr2N8UXDFf9MxvqtjnHSMz0uY3ugYJ7XhpDaP2fX5NHn30bE1OhwdyHiDBQoxAlC4Mo9CHQqsjhCCi51leRSpInBlZqQSXmEClWvYzI4zKYosc40COxDL4AkblovSPGNcuIUAj3KskIXSjXMptRHaD5UX5ZGrzYi9rl9wuiQqlhS2sH4Fq2_EMGJv8d2nqAebldLKwkzgHsh0lk5CdGnBTw1H7Lg3E-yq7g2_qqWX4hAmI5ZmsV2nnsSyfWNQjL_NETII_VCIEXtKom8e2o_RELrB0R3-_Zzda7-XYzbcrLbmBdtb59uXVkt_ATO8uoI |
link.rule.ids | 315,782,786,27935,27936 |
linkProvider | Oxford University Press |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Implementation+of+a+multidisciplinary+pharmacogenomics+clinic+in+a+community+health+system&rft.jtitle=American+journal+of+health-system+pharmacy&rft.au=Dunnenberger%2C+Henry+M&rft.au=Biszewski%2C+Matthew&rft.au=Bell%2C+Gillian+C&rft.au=Sereika%2C+Annette&rft.date=2016-12-01&rft.issn=1079-2082&rft.volume=73&rft.issue=23&rft.spage=1956&rft.epage=1966&rft_id=info:doi/10.2146%2Fajhp160072&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1079-2082&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1079-2082&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1079-2082&client=summon |